Recent YSCC Discoveries

Madeline Mayday, BS, a fourth-year Experimental Pathology graduate student in the Laboratory of Diane Krause, MD, PhD, was recently awarded a 2022 National Institute of Diabetes and Digestive and Kidney Diseases Hematology Centers Program Type B Pilot and Feasibility grant

In March 2020, Maricar Malinis, MD, FACP, FIDSA, FAST, and a group of colleagues were called to an emergency meeting. COVID-19 was on the horizon, and no one knew what to expect. The anxiety was palpable. The date itself was inauspicious: Friday the 13th.

Discoveries & Impact highlights select scientific discoveries for each of the 11 section in the Department of Internal Medicine.

The National Institutes of Health recently announced $100 million in awards over five years to support nine Autism Centers of Excellence (ACEs), one of which is a collaborative effort at the University of Virginia (UVA) involving several Yale faculty members.

It is with great sadness that we bid farewell to Ms. Susan Solomon, a beloved leader in promoting stem cell research and a dear friend of Yale Stem Center (see NYSCF announcement below). Susan left behind a legacy that will continue to inspire all of us!

A new video series produced by Medscape Video features physicians from Yale-PCCSM discussing the comorbidities associated with idiopathic pulmonary fibrosis.

Ryan Chow is the 2022 winner of the Genetics Department’s Carolyn Slayman Prize, which recognizes excellence in scientific research and contribution to the scientific community.

Marie Robert, MD, Professor of Pathology and of Medicine (Digestive Diseases), and Jordan Pober, MD, PhD, the Bayer Professor of Translational Medicine and Professor of Immunobiology, Pathology, and Dermatology, have been awarded a grant from the Program for the Promotion of Interdisciplinary Team Science (POINTS) at Yale School of Medicine to study the Pathogenesis of Celiac Disease.

A new study from Yale Cancer Center scientists has identified the chromatin regulator WDR5 as a possible new drug target in triple negative breast cancer.